Iron Dysregulation in Cardiovascular Diseases

被引:1
|
作者
Wang, Hui [1 ]
Huang, Zhongmin [1 ]
Du, Chenyan [1 ]
Dong, Mingqing [1 ]
Fragasso, Gabriele [1 ]
机构
[1] Chengdu Fifth Peoples Hosp, Geriatr Dis Inst Chengdu, Ctr Med Res & Translat, Chengdu 611137, Sichuan, Peoples R China
关键词
iron metabolism; homeostasis; cardiovascular disease; dysregulation; CHRONIC HEART-FAILURE; FERRIC CARBOXYMALTOSE; DEFICIENCY ANEMIA; HEREDITARY HEMOCHROMATOSIS; ENDOTHELIAL DYSFUNCTION; TRANSFERRIN RECEPTOR; EXERCISE CAPACITY; OXIDATIVE STRESS; OVERLOAD; HEPCIDIN;
D O I
10.31083/j.rcm2501016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Iron metabolism plays a crucial role in various physiological functions of the human body, as it is essential for the growth and development of almost all organisms. Dysregulated iron metabolism-manifested either as iron deficiency or overload-is a significant risk factor for the development of cardiovascular disease (CVD). Moreover, emerging evidence suggests that ferroptosis, a form of iron-dependent programed cell death, may also contribute to CVD development. Understanding the regulatory mechanisms of iron metabolism and ferroptosis in CVD is important for improving disease management. By integrating different perspectives and expertise in the field of CVD-related iron metabolism, this overview provides insights into iron metabolism and CVD, along with approaches for diagnosing, treating, and preventing CVD associated with iron dysregulation.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload
    Bi, Yaguang
    Ajoolabady, Amir
    Demillard, Laurie J.
    Yu, Wenjun
    Hilaire, Michelle L.
    Zhang, Yingmei
    Ren, Jun
    BIOCHEMICAL PHARMACOLOGY, 2021, 190
  • [2] Dysregulation of Mitochondrial Homeostasis in Cardiovascular Diseases
    Patil, Ricky
    Wang, Hui
    Kazaleh, Matthew
    Ailawadi, Gorav
    Salmon, Morgan
    PHARMACEUTICALS, 2025, 18 (01)
  • [3] Iron and cardiovascular diseases
    Naito, Yoshiro
    Masuyama, Tohru
    Ishihara, Masaharu
    JOURNAL OF CARDIOLOGY, 2021, 77 (02) : 160 - 165
  • [4] Dysregulation of Histone Acetyltransferases and Deacetylases in Cardiovascular Diseases
    Wang, Yonggang
    Miao, Xiao
    Liu, Yucheng
    Li, Fengsheng
    Liu, Quan
    Sun, Jian
    Cai, Lu
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2014, 2014
  • [5] miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives
    Sessa, Francesco
    Salerno, Monica
    Esposito, Massimiliano
    Cocimano, Giuseppe
    Pomara, Cristoforo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [6] Dysregulation of Calcium Homeostasis: An Important Factor Leading to Ferroptosis in Cardiovascular Diseases
    Zhang, Yifan
    Zheng, Leiyin
    Che, Tongtong
    Meng, Ning
    CELL BIOLOGY INTERNATIONAL, 2025,
  • [7] The role of labile iron pool in cardiovascular diseases
    Kruszewski, M
    ACTA BIOCHIMICA POLONICA, 2004, 51 (02) : 471 - 480
  • [8] Myocardial Iron Metabolism in the Regulation of Cardiovascular Diseases in Rats
    Zhao, Na
    Sun, Zhidan
    Mao, Yuying
    Hang, Pengzhou
    Jiang, Xing
    Sun, Lihua
    Zhao, Jinlong
    Du, Zhimin
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2010, 25 (06) : 587 - 594
  • [9] THE IMPACT OF IRON LEVELS IN THE BLOOD ON NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES
    Belbellaj, Wiame
    Gagliano-Taliun, Sarah
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023, 75 : S128 - S128
  • [10] Adipokines and cardiovascular dysregulation
    Fernandez-Alfonso, M.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S4 - S4